Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03767153 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring
A NA study, sponsored by Venus Concept.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03767153 is a NA study that has completed, run by Venus Concept. The registered enrollment target is 25 participants.
The verdict
NCT03767153, a NA study, has completed, sponsored by Venus Concept.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate 50 treatment sites in subjects requesting treatment of their acne scarring. The study will involve three treatments on both sides of the face with 3-5 week intervals between each treatment. Subjects will be followed at 6 and 12 weeks after their last treatment. Analysis will be performed on all subjects who receive at least one treatment.
Interventions
- DEVICE Venus Viva
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-11-05 |
| Est. Completion | 2019-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03767153
The ClinicalTrials.gov registry entry for NCT03767153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venus Viva is the first listed.
NCT03767153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03767153 about?
NCT03767153 is a clinical study titled "Clinical Evaluation of Fractional Radiofrequency for the Treatment of Acne Scarring". Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of acne scarring. The study will evaluate 50 treatment sites in subjects requesting treatment of their acne scarring. The study will involve three treatme...
What is the current status of trial NCT03767153?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-11-05. Estimated completion is 2019-12-22.
What interventions are being tested in trial NCT03767153?
The interventions under investigation include: Venus Viva (DEVICE).
Who is sponsoring clinical trial NCT03767153?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.